Solvay
Market Cap
€9.1b
Last Updated
2019/08/23 20:44 UTC
Data Sources
Company Financials +
Executive Summary
Solvay SA operates as an advanced materials and specialty chemicals worldwide.
Snowflake
Fundamentals
Good value average dividend payer.
Similar Companies
Share Price & News
How has Solvay's share price performed over time and what events caused price changes?
Latest Share Price and Events
Market Performance
7 Day Return
1.8%
ENXTBR:SOLB
0.5%
BE Chemicals
-0.2%
BE Market
1 Year Return
-22.6%
ENXTBR:SOLB
-30.3%
BE Chemicals
-4.8%
BE Market
SOLB outperformed the Chemicals industry which returned -28.8% over the past year.
SOLB underperformed the Market in Belgium which returned -4.3% over the past year.
Share holder returns
| SOLB | Industry | Market | |
|---|---|---|---|
| 7 Day | 1.8% | 0.5% | -0.2% |
| 30 Day | -7.2% | -6.8% | -3.6% |
| 90 Day | 4.3% | 0.6% | 5.5% |
| 1 Year | -20.2%-22.6% | -28.7%-30.3% | -2.7%-4.8% |
| 3 Year | -3.0%-9.7% | 2.4%-3.6% | -5.8%-12.5% |
| 5 Year | -11.1%-26.0% | 10.7%-6.6% | 21.2%6.0% |
Price Volatility Vs. Market
How volatile is Solvay's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 week ago | Simply Wall St
Should We Be Cautious About Solvay SA's (EBR:SOLB) ROE Of 7.8%?3 weeks ago | Simply Wall St
With 2.5% Earnings Growth, Did Solvay SA (EBR:SOLB) Outperform The Industry?1 month ago | Simply Wall St
Here's Why Solvay (EBR:SOLB) Can Manage Its Debt ResponsiblyValuation
Is Solvay undervalued based on future cash flows and its price relative to the stock market?
26%
Discount to future cash flow value
Intrinsic Value Based on Future Cash Flows
Solvay's share price is below the future cash flow value, and at a moderate discount (> 20%).
Solvay's share price is below the future cash flow value, but not at a substantial discount (< 40%).
Price Based on Earnings
Solvay is good value based on earnings compared to the BE Chemicals industry average.
Solvay is good value based on earnings compared to the Belgium market.
Price Based on Expected Growth
Solvay is poor value based on expected growth next year.
Price Based on Value of Assets
Solvay is good value based on assets compared to the BE Chemicals industry average.
Next Steps
Future Growth
How is Solvay expected to perform in the next 1 to 3 years based on estimates from 14 analysts?
5.5%
Forecasted annual earnings growth
Earnings and Revenue Growth Estimates
Future Annual Growth Analysis
Solvay's revenue is expected to grow by 2.5% yearly, however this is not considered high growth (20% yearly).
Solvay's earnings are expected to grow by 5.5% yearly, however this is not considered high growth (20% yearly).
Solvay's revenue growth is positive but not above the Belgium market average.
Solvay's earnings growth is positive but not above the Belgium market average.
Solvay's earnings growth is expected to exceed the low risk savings rate of 0.8%.
Earnings per Share Growth Estimates
Future Return on Equity
Solvay is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).
Next Steps
Past Performance
How has Solvay performed over the past 5 years?
23.0%
Historical annual earnings growth
Earnings and Revenue History
Past Earnings Growth Analysis
Solvay has delivered over 20% year on year earnings growth in the past 5 years.
Solvay's 1-year earnings growth is negative, it can't be compared to the 5-year average.
Solvay's 1-year earnings growth is negative, it can't be compared to the BE Chemicals industry average.
Return on Equity
Solvay has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
Return on Assets
Solvay used its assets less efficiently than the BE Chemicals industry average last year based on Return on Assets.
Return on Capital Employed
Solvay has significantly improved its use of capital last year versus 3 years ago (Return on Capital Employed).
Next Steps
Financial Health
How is Solvay's financial position?
Financial Position Analysis
Solvay is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
Solvay's long term commitments exceed its cash and other short term assets.
Debt to Equity History and Analysis
Solvay's level of debt (53.1%) compared to net worth is high (greater than 40%).
The level of debt compared to net worth has increased over the past 5 years (40.1% vs 53.1% today).
Debt is well covered by operating cash flow (34.8%, greater than 20% of total debt).
Interest payments on debt are well covered by earnings (EBIT is 10.4x coverage).
Balance Sheet
High level of physical assets or inventory.
Debt is covered by short term assets, assets are 1.3x debt.
Next Steps
Dividend
What is Solvay's current dividend yield, its reliability and sustainability?
4.45%
Expected Dividend Yield
Dividend Yield and Payments Analysis
Solvay's pays a higher dividend yield than the bottom 25% of dividend payers in Belgium (2.27%).
Solvay's dividend is below the markets top 25% of dividend payers in Belgium (4.58%).
Dividends per share have been volatile in the past 10 years (annual drop of over 20%).
Dividends per share have increased over the past 10 years.
Current Payout to Shareholders
Dividends paid are well covered by earnings (3.1x coverage).
Future Payout to Shareholders
Dividends after 3 years are expected to be well covered by earnings (2.4x coverage).
Next Steps
Management
What is the CEO of Solvay's salary, the management and board of directors tenure and is there insider trading?
2.6yrs
Average management tenure
CEO
Ilham Kadri (50yo)
0.4yrs
Tenure
Dr. Ilham Kadri has been Chief Executive Officer and Director at Solvay SA since March 1, 2019. Dr. Kadri was an Executive Officer of Solvay SA since January 1, 2019 until March 1, 2019. Dr. Kadri served a ...
Management Age and Tenure
2.6yrs
Average Tenure
55yo
Average Age
The tenure for the Solvay management team is about average.
Board Age and Tenure
8.4yrs
Average Tenure
61yo
Average Age
The tenure for the Solvay board of directors is about average.
Insider Trading
No 3 month open market individual insider trading information.
Ownership Breakdown
Management Team
Vincent Paul Jean De Cuyper (58yo)
Member of Executive Committee
- Tenure: 13.6yrs
Hua Du (50yo)
President of the GBU Special Chem & Member of the Executive Committee
- Tenure: 1.5yrs
Pascal Juéry (54yo)
President of Solvay Essential Chemicals & Member of the Executive Committee
- Tenure: 5.6yrs
Quitterie De Pelleport (42yo)
Head of Legal & Compliance and Group General Counsel
- Tenure: 2.6yrs
Ilham Kadri (50yo)
Chairman of the Executive Committee
- Tenure: 0.4yrs
Cécile de Marsac (56yo)
Group GM of Human Resources & Member of the Executive Committee
- Tenure: 1.6yrs
Karim Hajjar (56yo)
CFO & Member of the Executive Committee
- Tenure: 5.8yrs
Canet-Teil Cecile
Group General Manager of Communications
- Tenure: 3.5yrs
Augusto Di Donfrancesco (60yo)
President of Specialty Polymers & Member of the Executive Committee
- Tenure: 1.5yrs
Geoffroy Raskin
Head of Investor Relations
- Tenure: 0.0yrs
Board Members
Rosemary Thorne (67yo)
Independent Director
- Tenure: 5.3yrs
Nicolas Boël (57yo)
Chairman
- Tenure: 7.3yrs
- Compensation: €325.00k
Bernard de Laguiche (60yo)
Non-Executive Director
- Tenure: 13.6yrs
Jean-Marie Solvay de la Hulpe (63yo)
Non-Independent Director
- Tenure: 28.6yrs
Charles Casimir-Lambert (52yo)
Independent Director
- Tenure: 12.3yrs
Maria Amparo Moraleda Martinez (55yo)
Independent Director
- Tenure: 6.1yrs
Hervé d'Eeckenbrugge (62yo)
Independent Director
- Tenure: 10.6yrs
Evelyn du Monceau (69yo)
Independent Director
- Tenure: 9.6yrs
Ilham Kadri (50yo)
Chairman of the Executive Committee
- Tenure: 0.4yrs
Françoise de Viron (64yo)
Independent Director
- Tenure: 6.1yrs
Company Information
Solvay SA's company bio, employee growth, exchange listings and data sources
Key Information
- Name: Solvay SA
- Ticker: SOLB
- Exchange: ENXTBR
- Founded: 1863
- Industry: Diversified Chemicals
- Sector: Materials
- Market Cap: €9.141b
- Shares outstanding: 103.15m
- Website: https://www.solvay.com
Number of Employees
Location
- Solvay SA
- Rue de Ransbeek, 310
- Brussels
- Brussels
- 1120
- Belgium
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| SVYS.F | OTCPK (Pink Sheets LLC) | Yes | Ordinary Shares | US | USD | Jan 1992 |
| SOLB | ENXTBR (Euronext Brussels) | Yes | Ordinary Shares | BE | EUR | Jan 1992 |
| SOL | DB (Deutsche Boerse AG) | Yes | Ordinary Shares | DE | EUR | Jan 1992 |
| 0NZR | LSE (London Stock Exchange) | Yes | Ordinary Shares | GB | EUR | Jan 1992 |
| SOLBB | BATS-CHIXE (BATS 'Chi-X Europe') | Yes | Ordinary Shares | GB | EUR | Jan 1992 |
| SOL | BRSE (Berne Stock Exchange) | Yes | Ordinary Shares | CH | EUR | Jan 1992 |
| SOLB | WBAG (Wiener Boerse AG) | Yes | Ordinary Shares | AT | EUR | Jan 1992 |
| SOLV.Y | OTCPK (Pink Sheets LLC) | SPONSORED ADR | US | USD | Aug 2010 |
Biography
Solvay SA operates as an advanced materials and specialty chemicals worldwide. It operates through four segments: Advanced Materials, Advanced Formulations, Performance Chemicals, and Corporate & Business ...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2019/08/23 20:44 |
| End of Day Share Price | 2019/08/23 00:00 |
| Earnings | 2019/06/30 |
| Annual Earnings | 2018/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.